## Company Overview

**Legal Name:** Abridge  
**Brand Name:** Abridge  
**Website:** [abridge.com](https://www.abridge.com/)  
**Headquarters:** Pittsburgh, Pennsylvania, United States  
**Founded Year:** 2018  
**Categories:** Medical AI, Digitally-Assisted Provider Documentation  

Abridge is a private AI startup focused on transforming healthcare documentation through AI-powered solutions. The company is headquartered in Pittsburgh and was founded in 2018. It operates within the medical AI and digitally-assisted provider documentation sectors.

## Business Model and GTM

Abridge offers a suite of AI-driven products designed to enhance clinical documentation processes. Key products include:

- **Abridge AI Platform:** Transforms patient-clinician conversations into structured clinical notes in real-time with deep EMR integrations.
- **Abridge Mobile Application:** A software and mobile application product.
- **Abridge Gen AI for Emergency Care:** Integrates with Epicâ€™s note drafting workflows for emergency department clinicians.
- **Abridge AI Scribe:** Uses ambient listening and natural language processing to create transcripts and draft clinical notes.
- **Abridge Inside:** Allows clinicians to transform conversations into structured notes without leaving Epic Haiku or Hyperspace.

The company states that its products are purpose-built for healthcare, aiming to streamline documentation and improve clinical workflows.

## Funding & Investor Profile

**Total Raised:** $800 million  
**Last Disclosed Valuation:** $5.3 billion  
**Last Funding Round:** Series E  
**Last Round Date:** June 1, 2025  

Abridge has successfully raised significant capital, with a total of $800 million in funding. The most recent Series E round, led by Andreessen Horowitz with participation from Khosla Ventures, raised $300 million and brought the company's valuation to $5.3 billion. Previous investors include IVP, Bessemer Venture Partners, Lightspeed Venture Partners, NVentures (NVIDIA), Redpoint Ventures, and Spark Capital.

## Growth Momentum

Abridge has demonstrated growth through strategic funding rounds and product releases. The company has raised substantial capital in Series D and E rounds, indicating strong investor confidence. Additionally, Abridge has expanded its product offerings, including the release of Abridge Inside, which integrates with Epic systems to enhance clinician workflows.

## Visibility & Market Sentiment

Abridge has partnered with the American Medical Informatics Association (AMIA) as a Platinum Corporate Partner for the 2025 calendar year, suggesting a positive market presence and alignment with industry standards.

## Risks and Challenges

Not disclosed.

## Outlook

Abridge is positioned for continued growth in the healthcare AI sector, supported by strong investor backing and a comprehensive suite of products designed to improve clinical documentation. The company's partnerships and integrations with major healthcare systems like Epic further enhance its market potential.

## Disclosure Gaps

- Specific details on leadership roles and responsibilities are not disclosed.
- Market sentiment and visibility metrics are not fully detailed.
- Risks and challenges facing the company are not disclosed.
- Specific go-to-market strategies and customer acquisition details are not provided.